Metabolic And Atherosclerosis Research Center

Cincinnati, Ohio 45212

Use our guide to learn which trials are right for you!

We've found
7 trials
at this facility
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Status: Enrolling, Phase II
Updated: 3/2/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Heterozygous Familial Hypercholesterolemia Clinical Trial
A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials